Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marsh

Showing results (611-620 of 654) with videos related to

Pageof 66
Sort By:
Journal of Medicinal Chemistry|April 13, 2001
Discovery of inhibitors of cell adhesion molecule expression in human endothelial cells. 1. Selective inhibition of ICAM-1 and E-selectin expressionA O Stewart, P A Bhatia, C M McCarty, et al.
Journal of Medicinal Chemistry|January 23, 1998
Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonistsM L Curtin, S K Davidsen, H R Heyman, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1997
Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivoC A Briggs, D J Anderson, J D Brioni, et al.
Blood|May 1, 2012
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working PartyJudith C Marsh, Andrea Bacigalupo, Hubert Schrezenmeier, et al.
Journal of Medicinal Chemistry|April 15, 2005
Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activitiesFortuna Haviv, Michael F Bradley, Douglas M Kalvin, et al.
Blood|January 11, 2000
Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow TransplantationP Guardiola, R Pasquini, I Dokal, et al.
Journal of Medicinal Chemistry|March 28, 2009
2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effectsDavid A Degoey, David J Grampovnik, Charles A Flentge, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.
Bioorganic & Medicinal Chemistry|April 20, 2006
Structure-activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonistsIrene Drizin, Arthur Gomtsyan, Erol K Bayburt, et al.
Journal of Medicinal Chemistry|March 27, 2010
Optimization of phenyl-substituted benzimidazole carboxamide poly(ADP-ribose) polymerase inhibitors: identification of (S)-2-(2-fluoro-4-(pyrrolidin-2-yl)phenyl)-1H-benzimidazole-4-carboxamide (A-966492), a highly potent and efficacious inhibitorThomas D Penning, Gui-Dong Zhu, Jianchun Gong, et al.
Pageof 66

Showing results (611-620 of 654) with videos related to

Sort By:
Pageof 66
Journal of Medicinal Chemistry|April 13, 2001
Discovery of inhibitors of cell adhesion molecule expression in human endothelial cells. 1. Selective inhibition of ICAM-1 and E-selectin expressionA O Stewart, P A Bhatia, C M McCarty, et al.
Journal of Medicinal Chemistry|January 23, 1998
Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonistsM L Curtin, S K Davidsen, H R Heyman, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1997
Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivoC A Briggs, D J Anderson, J D Brioni, et al.
Blood|May 1, 2012
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working PartyJudith C Marsh, Andrea Bacigalupo, Hubert Schrezenmeier, et al.
Journal of Medicinal Chemistry|April 15, 2005
Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activitiesFortuna Haviv, Michael F Bradley, Douglas M Kalvin, et al.
Blood|January 11, 2000
Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow TransplantationP Guardiola, R Pasquini, I Dokal, et al.
Journal of Medicinal Chemistry|March 28, 2009
2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effectsDavid A Degoey, David J Grampovnik, Charles A Flentge, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.
Bioorganic & Medicinal Chemistry|April 20, 2006
Structure-activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonistsIrene Drizin, Arthur Gomtsyan, Erol K Bayburt, et al.
Journal of Medicinal Chemistry|March 27, 2010
Optimization of phenyl-substituted benzimidazole carboxamide poly(ADP-ribose) polymerase inhibitors: identification of (S)-2-(2-fluoro-4-(pyrrolidin-2-yl)phenyl)-1H-benzimidazole-4-carboxamide (A-966492), a highly potent and efficacious inhibitorThomas D Penning, Gui-Dong Zhu, Jianchun Gong, et al.
Pageof 66